Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Watching ASLAN Pharmaceuticals; Piper Sandler Out With Note Saying "Co Believes That A Partner Or Acquirer Will See The Value And Differentiation Of Once Monthly Subcutaneous Eblasakimab Vs. Every Other Week Dupixent"

Author: Benzinga Newsdesk | March 11, 2024 02:45pm

Posted In: ASLN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist